A detailed history of Fort Washington Investment Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 255,395 shares of ABBV stock, worth $45.8 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
255,395
Previous 255,438 0.02%
Holding current value
$45.8 Million
Previous $43.8 Million 15.12%
% of portfolio
0.31%
Previous 0.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$163.84 - $199.33 $7,045 - $8,571
-43 Reduced 0.02%
255,395 $50.4 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $367,626 - $429,305
-2,375 Reduced 0.92%
255,438 $43.8 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $2.66 Million - $3.03 Million
-16,665 Reduced 6.07%
257,813 $46.9 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $277,814 - $312,884
2,019 Added 0.74%
274,478 $42.5 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $417,468 - $483,281
3,125 Added 1.16%
272,459 $40.6 Million
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $34,982 - $43,533
-264 Reduced 0.1%
269,334 $36.3 Million
Q1 2023

Apr 28, 2023

SELL
$144.61 - $166.54 $681,980 - $785,402
-4,716 Reduced 1.72%
269,598 $43 Million
Q4 2022

Jan 30, 2023

SELL
$138.31 - $165.87 $551,165 - $660,991
-3,985 Reduced 1.43%
274,314 $44.3 Million
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $1.54 Million - $1.77 Million
-11,488 Reduced 3.96%
278,299 $37.4 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $3.41 Million - $4.34 Million
-24,814 Reduced 7.89%
289,787 $44.4 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $24.6 Million - $30.5 Million
-186,508 Reduced 37.22%
314,601 $51 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $4.21 Million - $5.32 Million
-39,168 Reduced 7.25%
501,109 $67.9 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $42.2 Million - $47.9 Million
396,901 Added 276.83%
540,277 $58.3 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $19,148 - $21,332
182 Added 0.13%
143,376 $16.2 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $186,288 - $205,081
1,821 Added 1.29%
143,194 $15.5 Million
Q4 2020

Feb 03, 2021

BUY
$80.49 - $108.67 $76,385 - $103,127
949 Added 0.68%
141,373 $15.1 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $373,107 - $437,904
-4,343 Reduced 3.0%
140,424 $12.3 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $767,156 - $1.03 Million
10,456 Added 7.78%
144,767 $14.2 Million
Q1 2020

May 06, 2020

BUY
$64.5 - $97.79 $313,663 - $475,552
4,863 Added 3.76%
134,311 $10.2 Million
Q4 2019

Feb 03, 2020

BUY
$72.13 - $90.25 $2.09 Million - $2.61 Million
28,921 Added 28.77%
129,448 $11.5 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $1.74 Million - $2.09 Million
27,562 Added 37.77%
100,527 $7.61 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $194,472 - $248,580
-2,960 Reduced 3.9%
72,965 $5.31 Million
Q1 2019

May 10, 2019

SELL
$77.14 - $90.79 $39,958 - $47,029
-518 Reduced 0.68%
75,925 $6.12 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $2.14 Million - $2.64 Million
-27,514 Reduced 26.47%
76,443 $7.05 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $724,705 - $805,644
-8,151 Reduced 7.27%
103,957 $9.83 Million
Q2 2018

Jul 27, 2018

SELL
$89.78 - $106.23 $11,222 - $13,278
-125 Reduced 0.11%
112,108 $10.4 Million
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $1.89 Million - $2.53 Million
-20,536 Reduced 15.47%
112,233 $10.6 Million
Q4 2017

Feb 12, 2018

SELL
$89.56 - $98.21 $18,807 - $20,624
-210 Reduced 0.16%
132,769 $12.8 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $305,803 - $390,605
4,378 Added 3.4%
132,979 $11.8 Million
Q2 2017

Aug 10, 2017

BUY
N/A
128,601
128,601 $9.33 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.